pharmacie et médicaments – Réduction des remises commerciales

This written question concerns the reduction of commercial rebates for pharmaceuticals and medicines in France. It seeks clarification on the implications and potential impact of such measures on the pharmaceutical sector and public health. The question addresses the French National Assembly and is relevant to healthcare providers, pharmaceutical companies, and patients who rely on access to medicines.